• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.29% Nasdaq Down0.03%

    Galectin Therapeutics, Inc. (GALT)

    -NasdaqCM
    2.75 Up 0.04(1.48%) May 22, 4:00PM EDT
    |After Hours : 2.78 Up 0.03 (1.09%) May 22, 5:02PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development8,425  5,688  4,527  
    Selling General and Administrative7,005  6,416  5,372  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (15,430) (12,104) (9,899)
    Income from Continuing Operations
    Total Other Income/Expenses Net42  16  224  
    Earnings Before Interest And Taxes(15,388)(12,088)(9,675)
    Interest Expense -   -   -  
    Income Before Tax(15,388)(12,088)(9,675)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(15,788)(12,088)(9,675)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (15,788) (12,088) (9,675)
    Preferred Stock And Other Adjustments(1,172)(9,859)(1,206)
    Net Income Applicable To Common Shares (16,960) (21,947) (10,881)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.